Nordson Bulls Hold Ground as Q3 Print Arrives

Short interest remains a non-story heading in. Bears have trimmed exposure by roughly 9% over the past month, bringing SI to 2.9% of the free float — low enough that there is no meaningful short-side pressure on the stock. Borrow availability is exceptionally loose at over 5,000% of current short interest, with borrowing costs near 0.35%. The lending market offers no squeeze catalyst in either direction.

The analyst debate centres on a familiar fork. Bulls — led by DA Davidson and Oppenheimer, both of whom raised targets after the May print — point to M&A optionality, rising FY26–FY27 EPS estimates, and momentum in medical and fluid solutions. Bears, including BNP Paribas which holds a Neutral with a $290 target below the current price, flag margin headwinds from regulatory adjustments and uneven North American semiconductor demand. The consensus mean target of $320 implies only modest upside from here, suggesting the Street already reflects a fair amount of good news. Note that all recent analyst changes date from May 2026 or earlier, so the consensus has not been actively revised into this print.

The Q3 report is therefore a test of whether Nordson's organic growth trajectory and margin defence can justify the gap it has opened against its industrial peers — and whether the call buyers who repositioned decisively on the eve of results were reading the setup correctly.